HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients.
Li L, Gu Y, Zhang M, Shi X, Li Z, Xu X, Sun T, Dong Y, Xue C, Zhu X, Lv R, Jiao K, Ji X, Wang LJ, Zhang Y, Liang Z, Jin Y, Yin R, Wu M, Liang H.
Li L, et al. Among authors: zhang m, zhang y.
NPJ Precis Oncol. 2023 May 31;7(1):51. doi: 10.1038/s41698-023-00402-y.
NPJ Precis Oncol. 2023.
PMID: 37258600
Free PMC article.